Physician profile
Ruth W Wei
NPI 1710483938
$709.24
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.49 · 2022: $550 · 2023: $16.31 · 2024: $51.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.72 | 2022-2024 | |
| Neos Therapeutics, LP | $131.01 | 2022 | |
| Novo Nordisk INC | $129.01 | 2021-2022 | |
| Eisai INC. | $95.11 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $68.14 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.07 | 2021 | |
| Medtronic, INC. | $19.23 | 2024 | Interstim |
| Amarin Pharma, INC. | $17.82 | 2021 | |
| Abbott Laboratories | $16.31 | 2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $15.76 | 2021 | |
| Lilly USA, LLC | $13.63 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.